1. Home
  2. RPRX vs MKC Comparison

RPRX vs MKC Comparison

Compare RPRX & MKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • MKC
  • Stock Information
  • Founded
  • RPRX 1996
  • MKC N/A
  • Country
  • RPRX United States
  • MKC
  • Employees
  • RPRX N/A
  • MKC N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • MKC Packaged Foods
  • Sector
  • RPRX Health Care
  • MKC Consumer Staples
  • Exchange
  • RPRX Nasdaq
  • MKC Nasdaq
  • Market Cap
  • RPRX 15.6B
  • MKC 18.6B
  • IPO Year
  • RPRX 2020
  • MKC N/A
  • Fundamental
  • Price
  • RPRX $35.87
  • MKC $70.58
  • Analyst Decision
  • RPRX Strong Buy
  • MKC
  • Analyst Count
  • RPRX 3
  • MKC 0
  • Target Price
  • RPRX $45.33
  • MKC N/A
  • AVG Volume (30 Days)
  • RPRX 3.1M
  • MKC 2.3M
  • Earning Date
  • RPRX 08-06-2025
  • MKC 09-30-2025
  • Dividend Yield
  • RPRX 2.45%
  • MKC N/A
  • EPS Growth
  • RPRX 54.86
  • MKC 4.75
  • EPS
  • RPRX 2.32
  • MKC 2.87
  • Revenue
  • RPRX $2,305,243,000.00
  • MKC $6,742,800,000.00
  • Revenue This Year
  • RPRX $33.77
  • MKC N/A
  • Revenue Next Year
  • RPRX $4.62
  • MKC N/A
  • P/E Ratio
  • RPRX $15.45
  • MKC $24.52
  • Revenue Growth
  • RPRX 3.02
  • MKC 0.89
  • 52 Week Low
  • RPRX $24.05
  • MKC $68.23
  • 52 Week High
  • RPRX $38.00
  • MKC $86.24
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 42.45
  • MKC 46.85
  • Support Level
  • RPRX $35.48
  • MKC $68.69
  • Resistance Level
  • RPRX $36.99
  • MKC $70.77
  • Average True Range (ATR)
  • RPRX 0.68
  • MKC 1.33
  • MACD
  • RPRX -0.14
  • MKC 0.14
  • Stochastic Oscillator
  • RPRX 7.28
  • MKC 42.18

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About MKC McCormick & Company Incorporated

In its 135-year history, McCormick has become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond consumers, McCormick's customer base includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers. And its reach is extensive, with nearly 40% of sales generated beyond its home turf to 150 countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and Cholula, among others.

Share on Social Networks: